INCIDENCE OF NEPHROGENIC SYSTEMIC FIBROSIS AFTER ADMINISTRATION OF GADOTERIC ACID IN PATIENTS ON RENAL REPLACEMENT TREATMENT

被引:0
|
作者
Alfano, Gaetano [1 ]
Fontana, Francesco [1 ]
Ferrari, Annachiara [1 ]
Sollazzo, Andrea [1 ]
Torricelli, Pietro [1 ]
Cappelli, Gianni [1 ]
机构
[1] Univ Modena & Reggio Emilia, Modena, Italy
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
FP144
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Incidence of nephrogenic systemic fibrosis after administration of gadoteric acid in patients on renal replacement treatment
    Alfano, Gaetano
    Fontana, Francesco
    Ferrari, Annachiara
    Solazzo, Andrea
    Perrone, Rossella
    Giaroni, Francesco
    Torricelli, Pietro
    Cappelli, Gianni
    MAGNETIC RESONANCE IMAGING, 2020, 70 : 1 - 4
  • [2] No Cases of Nephrogenic Systemic Fibrosis after Administration of Gadoxetic Acid
    Starekova, Jitka
    Bruce, Richard J.
    Sadowski, Elizabeth A.
    Reeder, Scott B.
    RADIOLOGY, 2020, 297 (03) : 556 - 562
  • [3] Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure
    Othersen, Jennifer B.
    Maize, John C.
    Woolson, Robert F.
    Budisavljevic, Milos N.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (11) : 3179 - 3185
  • [4] Observational study on the incidence of nephrogenic systemic fibrosis in patients with renal impairment following gadoterate meglumine administration: the NSsaFe study.
    McWilliams, Richard G.
    Frabizzio, Jennifer, V
    De Backer, Adelard, I
    Grinberg, Anna
    Maes, Bart D.
    Zobel, Bruno Beomonte
    Gottschalk, Andreas
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 51 (02) : 607 - 614
  • [5] Gadobenate Dimeglumine Administration and Nephrogenic Systemic Fibrosis: Is There a Real Risk in Patients with Impaired Renal Function?
    Nandwana, Sadhna B.
    Moreno, Courtney C.
    Osipow, Michael T.
    Sekhar, Aarti
    Cox, Kelly L.
    RADIOLOGY, 2015, 276 (03) : 741 - 747
  • [6] Nephrogenic systemic fibrosis: An emerging disease in patients with renal failure
    Domsky, S.
    Telivala, B.
    Miller, J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 254 - 254
  • [7] Nephrogenic systemic fibrosis: An emerging threat among renal patients
    DeHoratius, DM
    Cowper, SE
    SEMINARS IN DIALYSIS, 2006, 19 (03) : 191 - 194
  • [8] Evaluation of the incidence of nephrogenic systemic fibrosis in patients with moderate renal insufficiency administered gadobenate dimeglumine for MRI
    Bryant, B. J., II
    Im, K.
    Broome, D. R.
    CLINICAL RADIOLOGY, 2009, 64 (07) : 706 - 713
  • [9] Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide
    Bruce, Richard
    Wentland, Andrew L.
    Haemel, Anna K.
    Garrett, Robert W.
    Sadowski, Donna R.
    Djamali, Arjang
    Sadowski, Elizabeth A.
    INVESTIGATIVE RADIOLOGY, 2016, 51 (11) : 701 - 705
  • [10] Imatinib in the Treatment of Nephrogenic Systemic Fibrosis
    Chandran, Sindhu
    Petersen, Jeffrey
    Jacobs, Charlotte
    Forentino, David
    Doeden, Katherine
    Lafayette, Richard A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (01) : 129 - 132